EPI 068
Alternative Names: EPI068Latest Information Update: 28 Sep 2022
At a glance
- Originator BioElectron Technology
- Class Antineoplastics
- Mechanism of Action Electron transport complex I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 28 Sep 2022 No recent reports of development identified for preclinical development in Solid-tumours in USA
- 22 Aug 2018 Preclinical trials in Solid tumours in USA (unspecified route) (BioElectron Technology pipeline, August 2018)